IBDEI1XJ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34260,1,4,0)
 ;;=4^N06.7
 ;;^UTILITY(U,$J,358.3,34260,2)
 ;;=^5015556
 ;;^UTILITY(U,$J,358.3,34261,0)
 ;;=N06.1^^192^1994^13
 ;;^UTILITY(U,$J,358.3,34261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34261,1,3,0)
 ;;=3^Isolated Proteinuria w/ Focal/Segmental Glomerular Lesions
 ;;^UTILITY(U,$J,358.3,34261,1,4,0)
 ;;=4^N06.1
 ;;^UTILITY(U,$J,358.3,34261,2)
 ;;=^5015550
 ;;^UTILITY(U,$J,358.3,34262,0)
 ;;=N06.0^^192^1994^14
 ;;^UTILITY(U,$J,358.3,34262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34262,1,3,0)
 ;;=3^Isolated Proteinuria w/ Minor Glomerular Abnormality
 ;;^UTILITY(U,$J,358.3,34262,1,4,0)
 ;;=4^N06.0
 ;;^UTILITY(U,$J,358.3,34262,2)
 ;;=^5015549
 ;;^UTILITY(U,$J,358.3,34263,0)
 ;;=N06.8^^192^1994^15
 ;;^UTILITY(U,$J,358.3,34263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34263,1,3,0)
 ;;=3^Isolated Proteinuria w/ Morphologic Lesion
 ;;^UTILITY(U,$J,358.3,34263,1,4,0)
 ;;=4^N06.8
 ;;^UTILITY(U,$J,358.3,34263,2)
 ;;=^5015557
 ;;^UTILITY(U,$J,358.3,34264,0)
 ;;=N14.3^^192^1994^24
 ;;^UTILITY(U,$J,358.3,34264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34264,1,3,0)
 ;;=3^Nephropathy Induced by Heavy Metals
 ;;^UTILITY(U,$J,358.3,34264,1,4,0)
 ;;=4^N14.3
 ;;^UTILITY(U,$J,358.3,34264,2)
 ;;=^5015593
 ;;^UTILITY(U,$J,358.3,34265,0)
 ;;=N14.1^^192^1994^23
 ;;^UTILITY(U,$J,358.3,34265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34265,1,3,0)
 ;;=3^Nephropathy Induced by Drug/Meds/Biol Subst
 ;;^UTILITY(U,$J,358.3,34265,1,4,0)
 ;;=4^N14.1
 ;;^UTILITY(U,$J,358.3,34265,2)
 ;;=^5015591
 ;;^UTILITY(U,$J,358.3,34266,0)
 ;;=N29.^^192^1994^16
 ;;^UTILITY(U,$J,358.3,34266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34266,1,3,0)
 ;;=3^Kidney and Ureter Disorders in Diseases Classd Elsewhr
 ;;^UTILITY(U,$J,358.3,34266,1,4,0)
 ;;=4^N29.
 ;;^UTILITY(U,$J,358.3,34266,2)
 ;;=^5015631
 ;;^UTILITY(U,$J,358.3,34267,0)
 ;;=N15.8^^192^1994^25
 ;;^UTILITY(U,$J,358.3,34267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34267,1,3,0)
 ;;=3^Renal Tubulo-Interstitial Diseases
 ;;^UTILITY(U,$J,358.3,34267,1,4,0)
 ;;=4^N15.8
 ;;^UTILITY(U,$J,358.3,34267,2)
 ;;=^5015595
 ;;^UTILITY(U,$J,358.3,34268,0)
 ;;=N14.4^^192^1994^26
 ;;^UTILITY(U,$J,358.3,34268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34268,1,3,0)
 ;;=3^Toxic Nephropathy NEC
 ;;^UTILITY(U,$J,358.3,34268,1,4,0)
 ;;=4^N14.4
 ;;^UTILITY(U,$J,358.3,34268,2)
 ;;=^5015594
 ;;^UTILITY(U,$J,358.3,34269,0)
 ;;=N05.6^^192^1994^18
 ;;^UTILITY(U,$J,358.3,34269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34269,1,3,0)
 ;;=3^Nephritic Syndrome w/ Dense Deposit Disease,Unspec
 ;;^UTILITY(U,$J,358.3,34269,1,4,0)
 ;;=4^N05.6
 ;;^UTILITY(U,$J,358.3,34269,2)
 ;;=^5015547
 ;;^UTILITY(U,$J,358.3,34270,0)
 ;;=N05.7^^192^1994^19
 ;;^UTILITY(U,$J,358.3,34270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34270,1,3,0)
 ;;=3^Nephritic Syndrome w/ Diffuse Crescentic Glomerulonephritis,Unspec
 ;;^UTILITY(U,$J,358.3,34270,1,4,0)
 ;;=4^N05.7
 ;;^UTILITY(U,$J,358.3,34270,2)
 ;;=^5015548
 ;;^UTILITY(U,$J,358.3,34271,0)
 ;;=N05.1^^192^1994^20
 ;;^UTILITY(U,$J,358.3,34271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34271,1,3,0)
 ;;=3^Nephritic Syndrome w/ Focal/Segmental Glomerular Lesions,Unspec
 ;;^UTILITY(U,$J,358.3,34271,1,4,0)
 ;;=4^N05.1
 ;;^UTILITY(U,$J,358.3,34271,2)
 ;;=^5015542
 ;;^UTILITY(U,$J,358.3,34272,0)
 ;;=N05.0^^192^1994^21
 ;;^UTILITY(U,$J,358.3,34272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34272,1,3,0)
 ;;=3^Nephritic Syndrome w/ Minor Glomerular Abnormality,Unspec
 ;;^UTILITY(U,$J,358.3,34272,1,4,0)
 ;;=4^N05.0
 ;;^UTILITY(U,$J,358.3,34272,2)
 ;;=^5015541
